Argonaute RNA Ltd

BiotechnologyBiotechnologyRNA interferenceGene Therapy

📍 Cardiff, United Kingdom• Founded 2015

StreetZero Signal 72

Be the first to signal interest

About Argonaute RNA Ltd

Argonaute RNA Ltd is a biotechnology company founded in 2015 focused on RNA interference and gene therapy. It develops siRNA-based therapeutics using a novel method of stabilising siRNA to enable safe and effective silencing of specific gene expression. The company is headquartered in Cardiff, United Kingdom, with operations linked to Bristol.

LATEST FUNDINGPrivate Placement

$1.8M

Announced 2026-09-24

TOTAL RAISED$2.28M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Argonaute RNA Ltd.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED2015

HQCardiff, United Kingdom

Industry

Biotechnology

Investors

Development Bank of Wales Empirical Ventures Bristol Private Equity Club CatSci Fink Family Office

Key highlights

Founded in 2015 and based in Cardiff, UK, Argonaute RNA develops stabilised siRNA for gene silencing.
Raised approximately $2.28M total with a noted Seed round in July 2024 per Tracxn data.
Backed by nine institutional investors including Development Bank of Wales and Empirical Ventures.
Focuses on overcoming obstacles in siRNA drug development for therapeutic applications.

Ask StreetZero about Argonaute RNA Ltd

Put our AI to work on this deal.

What is Argonaute RNA Ltd's value proposition?Who are Argonaute RNA Ltd's competitors?Why does this raise matter?Summarize Argonaute RNA Ltd for an investor.

Similar companies

Other Biotechnology deals, ranked by Signal.

Caspian Therapeutics, Inc.

$50.0M

Pictura Bio US, Inc.

$15.0M

Typewriter Therapeutics, Inc.

$56.3M

BioStem Technologies, Inc.

$40.0M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.